HBME-1 and antithrombomodulin in the differential diagnosis of malignant mesothelioma of pleura.
A D Kennedy(Aberdeen Royal Infirmary), Keith M. Kerr(University of Aberdeen)
Cited by 51
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|2.3k
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
|Nature Reviews Clinical Oncology|2021|1.5k
Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2023|782
The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung Cancer
|Journal of Thoracic Oncology|2020|184